Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Lipson

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|May 19, 2021
Reply to: "Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies" [Letter]Neil C Barnes, Dave Singh, David A Lipson
Ecology|June 25, 2019
Invasion and drought alter phenological sensitivity and synergistically lower ecosystem productionEllen H Esch, David A Lipson, Elsa E Cleland
Applied and Environmental Microbiology|December 8, 2005
Effects of elevated atmospheric CO2 on soil microbial biomass, activity, and diversity in a chaparral ecosystemDavid A Lipson, Richard F Wilson, Walter C Oechel
Oecologia|March 18, 2017
Non-mycorrhizal uptake of amino acids by roots of the alpine sedge Kobresia myosuroides: implications for the alpine nitrogen cycleTheodore K Raab, David A Lipson, Russell K Monson
The New England Journal of Medicine|August 9, 2018
Single-Inhaler Triple versus Dual Therapy in Patients with COPDDavid A Lipson, Gerard J Criner, David A Lomas
The American Journal of Managed Care|September 10, 2011
Inappropriate antibiotic prescribing in managed care subjects with influenzaDerek A Misurski, David A Lipson, Arun K Changolkar
American Journal of Respiratory and Critical Care Medicine|May 13, 2020
Reply to Suissa: Mortality in IMPACT: Confounded by Asthma?David A Lipson, Mark T Dransfield, MeiLan K Han
Advances in Therapy|September 8, 2018
Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β<sub>2</sub>-Agonist Therapy: An Integrated Post Hoc AnalysisIan P Naya, Lee Tombs, David A Lipson, et al.
Frontiers in Microbiology|March 30, 2026
Spatial biogeography of microbes in soils vs. aquatic ecosystems in U.S.'s major natural biomesLeo Oo Sai, Xinhao Zhu, David A Lipson, et al.
Advances in Therapy|October 4, 2020
24-Hour Serial Spirometric Assessment of Once-Daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULFIL StudyDavid A Lipson, Ruby Birk, Noushin Brealey, et al.
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
International Journal of Chronic Obstructive Pulmonary Disease|May 19, 2021
Reply to: "Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies" [Letter]Neil C Barnes, Dave Singh, David A Lipson
Ecology|June 25, 2019
Invasion and drought alter phenological sensitivity and synergistically lower ecosystem productionEllen H Esch, David A Lipson, Elsa E Cleland
Applied and Environmental Microbiology|December 8, 2005
Effects of elevated atmospheric CO2 on soil microbial biomass, activity, and diversity in a chaparral ecosystemDavid A Lipson, Richard F Wilson, Walter C Oechel
Oecologia|March 18, 2017
Non-mycorrhizal uptake of amino acids by roots of the alpine sedge Kobresia myosuroides: implications for the alpine nitrogen cycleTheodore K Raab, David A Lipson, Russell K Monson
The New England Journal of Medicine|August 9, 2018
Single-Inhaler Triple versus Dual Therapy in Patients with COPDDavid A Lipson, Gerard J Criner, David A Lomas
The American Journal of Managed Care|September 10, 2011
Inappropriate antibiotic prescribing in managed care subjects with influenzaDerek A Misurski, David A Lipson, Arun K Changolkar
American Journal of Respiratory and Critical Care Medicine|May 13, 2020
Reply to Suissa: Mortality in IMPACT: Confounded by Asthma?David A Lipson, Mark T Dransfield, MeiLan K Han
Advances in Therapy|September 8, 2018
Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β<sub>2</sub>-Agonist Therapy: An Integrated Post Hoc AnalysisIan P Naya, Lee Tombs, David A Lipson, et al.
Frontiers in Microbiology|March 30, 2026
Spatial biogeography of microbes in soils vs. aquatic ecosystems in U.S.'s major natural biomesLeo Oo Sai, Xinhao Zhu, David A Lipson, et al.
Advances in Therapy|October 4, 2020
24-Hour Serial Spirometric Assessment of Once-Daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULFIL StudyDavid A Lipson, Ruby Birk, Noushin Brealey, et al.
Pageof 14